CSIMarket



Kymera Therapeutics Inc.  (KYMR)
Other Ticker:  
 

Cumulative Kymera Therapeutics's Quick Ratio for Trailing Twelve Months Period

KYMR's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:

KYMR Quick Ratio for Trailing Twelve Months Period

(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
Y / Y Current Liabilities Growth 27.15 % 61.58 % 107.77 % - -
Y / Y Cash & cash equivalent Growth 17.62 % 42.07 % 82.54 % - -
Quick Ratio for Trailing Twelve Months Period 17.82 18.19 18.7 18.65 20.15
Total Ranking # 866 # 992 # # 888 # 1034
Seq. Current Liabilities Growth 1.94 % -2.87 % 7.27 % 19.72 % 29.54 %
Seq. Cash & cash equivalent Growth -6.77 % -21.55 % 49.37 % 7.67 % 12.6 %


Quick Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Due to rise in Current Liabilities in the II. Quarter to $24 millions, average cumulative Quick Ratio for Trailing Twelve Months Period decreased to 17.82 below Kymera Therapeutics Inc. average Quick Ratio for Trailing Twelve Months Period.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Biotechnology & Pharmaceuticals industry 136 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Kymera Therapeutics. While Quick Ratio for Trailing Twelve Months Period overall ranking has improved so far to 866, from total ranking in previous quarter at 992.

What is Quick Ratio?
Learn more about KYMR
Quick Ratio KYMR in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 137
Sector # 460
S&P 500 # 858


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
4.51 3.59 2.78
(Jun 30 2022)   (Mar 31 2021)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Jun 30 2022, within Biotechnology & Pharmaceuticals Industry Quick Ratio for Trailing Twelve Months Period
Singular Genomics Systems Inc.  43.03 
Cabaletta Bio Inc.  41.06 
Acumen Pharmaceuticals Inc.  37.39 
Talaris Therapeutics Inc.  35.49 
Athira Pharma Inc.  35.31 
Organovo Holdings Inc.  29.31 
Protara Therapeutics Inc.  28.59 
Cardiff Oncology inc   28.17 
Cocrystal Pharma Inc.  27.25 
Miromatrix Medical Inc   27.06 
Monte Rosa Therapeutics Inc.  25.45 
Vor Biopharma Inc.  25.21 
Replimune Group Inc.  24.42 
Aura Biosciences Inc.  23.62 
Freeline Therapeutics Holdings Plc  22.68 
Fusion Pharmaceuticals Inc.  22.62 
Rubius Therapeutics Inc.  21.56 
Citius Pharmaceuticals Inc.  21.46 
Crispr Therapeutics Ag  20.84 
Lixte Biotechnology Holdings Inc.  20.24 
Dyne Therapeutics Inc.  20.22 
Acasti Pharma Inc.  20.07 
4d Molecular Therapeutics Inc.  19.54 
Strongbridge Biopharma plc  19.44 
Vicarious Surgical Inc.  19.32 
Icosavax Inc.  19.21 
Humacyte Inc.  17.95 
Century Therapeutics inc.  17.56 
Bionano Genomics Inc.  17.24 
Salarius Pharmaceuticals inc.  17.17 


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

BLNC's Profile

Stock Price

BLNC's Financials

Business Description

Fundamentals

Charts & Quotes

BLNC's News

Suppliers

BLNC's Competitors

Customers & Markets

Economic Indicators

BLNC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071